U.S. market Closed. Opens in 11 hours 52 minutes

INM | InMed Pharmaceuticals Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-07-312003-07-312002-07-312001-07-31
Revenue4.14M1.09MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A39.66K79.46K168.42K623.37K1.74M2.76M4.23M2.09M185.61K13.77K2.44K
Cost of Revenue2.73M545.89K197.03K183.09K93.94KN/AN/AN/AN/AN/AN/AN/AN/A8.76K108.89K405.58K1.82M1.42M3.19M1.20M90.02K17.16K17.02K
Gross Profit1.40M543.55K-197.03K-183.09K-93.94KN/AN/AN/AN/AN/AN/AN/A39.66K70.71K59.53K217.79K-80.56K1.34M1.04M892.20K95.59K-3.39K-14.58K
Operating Expenses9.78M14.34M9.94M8.87M10.39M6.55M3.44M1.84M3.46M1.15M46.75K168.60K427.21K482.11K836.53K1.49M1.69M2.52M3.03M2.13M1.38M2.75M4.24M
Selling, General & Admin5.85M6.87M4.48M3.50M6.00M4.99M3.64M1.59M3.12M1.12M46.75KN/A314.36K300.73K536.37KN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development3.73M7.28M5.34M5.20M4.30M1.47M573.72K292.84K759.85K57.87KN/A17.03KN/A118.42K116.94K236.23K212.64KN/AN/AN/AN/AN/AN/A
Other Operating Expenses-308.94K185.66K120.87K161.97K94.72K89.60K-769.06K-45.23K-422.68K-23.55KN/A151.57K112.85K62.96K183.22K1.25M1.48M2.52M3.03M2.13M1.38M2.75M4.24M
Operating Income-8.18B-13.70M-9.92M-8.74M-10.36M-6.55M-3.44M-1.84M-3.46M-1.15M-46.75K-168.60K-387.56K-411.40K-777.00K-1.27M-1.77M-1.18M-1.99M-1.24M-1.28M-2.75M-4.25M
Other Expenses / Income-48.17K-4.90M-280.82K60.73K262.10K218.00-247.00-23.00-1.76K-846.0010.00-21.31K-73.79K-104.25K-276.94K-230.10K-17.47K-20.14K-760.73K-267.57K543.00-32.91K1.96M
Before Tax Income-7.93M-18.60M-10.20M-8.68M-10.10M-6.48M-3.44M-1.84M-3.46M-1.15M-46.74K-189.91KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses13.10K4.81M360.35K18.62K-262.10K-134.77KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-7.95M-23.41M-10.56M-8.70M-9.83M-6.48M-3.44M-1.84M-3.46M-1.15M-46.74K-189.91K-325.47K-334.79K-1.06M-922.26K-1.87M-1.27M-2.78M-1.52M-1.23M-2.71M-4.27M
Interest ExpensesN/A96.09K360.35K18.62KN/A67.17KN/AN/AN/AN/AN/AN/A11.70K27.63K5.90KN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding2.45M560.75K268.79K208.83K207.09K172.67K117.33K1.82M1.40M1.05M1.02M1.02M435.63K117.50K94.45K84.71K63.72K43.97K26.75K13.60K6.30K6.38K5.07K
Diluted Shares Outstanding2.45M560.83K268.79K208.83K207.09K172.67K117.33K1.82M1.40M1.05M1.02M1.02M435.63K117.50K94.45K85.30K65.92K43.97K26.75K13.60K6.30K6.38K5.07K
EBITDA-7.73M-13.18M-9.80M-8.58M-10.26M-6.46M-3.36M-1.77M-3.38M-1.15M-46.75K-168.59K-178.25K-237.65K-885.18K-839.02K-1.70M-1.02M-2.35M-1.22M-849.69K212.34K-877.92K
EBITDA Margin-187.03%-1,210.16%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-449.46%-299.07%-525.57%-134.59%-98.13%-36.99%-55.58%-58.49%-457.78%1,542.16%-35,940.53%
EBIT-7.93M-18.50M-9.84M-8.66M-10.10M-6.55M-3.44M-1.84M-3.46M-1.15M-46.74K-189.91K-313.76K-307.15K-1.05M-922.26K-1.87M-1.27M-2.78M-1.52M-1.23M-2.71M-4.27M
EBIT Margin-191.86%-1,698.50%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-791.17%-386.53%-625.77%-147.95%-107.89%-46.14%-65.65%-72.63%-662.88%-19,696.46%-174,750.87%
Financial Year End2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-07-312003-07-312002-07-312001-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙